DKK 94.26
(-0.06%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 3.73 Billion DKK | -63.09% |
2022 | 10.12 Billion DKK | 3.09% |
2021 | 9.82 Billion DKK | 82.16% |
2020 | 5.39 Billion DKK | -5.42% |
2019 | 5.7 Billion DKK | 48.41% |
2018 | 3.84 Billion DKK | 9.52% |
2017 | 3.5 Billion DKK | -0.54% |
2016 | 3.52 Billion DKK | 53.55% |
2015 | 2.29 Billion DKK | 37.13% |
2014 | 1.67 Billion DKK | 37.75% |
2013 | 1.21 Billion DKK | 340.58% |
2012 | 276 Million DKK | -79.91% |
2011 | 1.37 Billion DKK | 30.11% |
2010 | 1.05 Billion DKK | -1.31% |
2009 | 1.07 Billion DKK | -33.21% |
2008 | 1.6 Billion DKK | 23.04% |
2007 | 1.3 Billion DKK | 4.16% |
2006 | 1.25 Billion DKK | 203.4% |
2005 | 412 Million DKK | 258.26% |
2004 | 115 Million DKK | -82.52% |
2003 | 658 Million DKK | -50.6% |
2002 | 1.33 Billion DKK | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 4.51 Billion DKK | 51.04% |
2024 Q1 | 2.99 Billion DKK | -15.17% |
2023 Q4 | 3.73 Billion DKK | -51.77% |
2023 Q2 | 7.7 Billion DKK | -37.81% |
2023 FY | 3.73 Billion DKK | -63.09% |
2023 Q1 | 12.39 Billion DKK | 22.38% |
2023 Q3 | 7.75 Billion DKK | 0.56% |
2022 Q2 | 11 Billion DKK | 0.22% |
2022 FY | 10.12 Billion DKK | 3.09% |
2022 Q3 | 11 Billion DKK | 0.07% |
2022 Q4 | 10.12 Billion DKK | -8.0% |
2022 Q1 | 10.97 Billion DKK | 11.74% |
2021 Q3 | 5.75 Billion DKK | 0.21% |
2021 Q2 | 5.74 Billion DKK | -0.31% |
2021 Q1 | 5.76 Billion DKK | 6.9% |
2021 FY | 9.82 Billion DKK | 82.16% |
2021 Q4 | 9.82 Billion DKK | 70.59% |
2020 Q3 | 5.54 Billion DKK | 7.57% |
2020 Q1 | 5.72 Billion DKK | 0.44% |
2020 FY | 5.39 Billion DKK | -5.42% |
2020 Q2 | 5.15 Billion DKK | -10.08% |
2020 Q4 | 5.39 Billion DKK | -2.65% |
2019 Q1 | 3.61 Billion DKK | -5.99% |
2019 FY | 5.7 Billion DKK | 48.41% |
2019 Q4 | 5.7 Billion DKK | 33.19% |
2019 Q3 | 4.28 Billion DKK | 0.19% |
2019 Q2 | 4.27 Billion DKK | 18.3% |
2018 Q2 | 3.74 Billion DKK | -2.45% |
2018 FY | 3.84 Billion DKK | 9.52% |
2018 Q4 | 3.84 Billion DKK | -2.78% |
2018 Q3 | 3.95 Billion DKK | 5.47% |
2018 Q1 | 3.84 Billion DKK | 9.49% |
2017 FY | 3.5 Billion DKK | -0.54% |
2017 Q3 | 3.34 Billion DKK | 0.24% |
2017 Q2 | 3.34 Billion DKK | -2.68% |
2017 Q1 | 3.43 Billion DKK | -2.67% |
2017 Q4 | 3.5 Billion DKK | 4.75% |
2016 Q4 | 3.52 Billion DKK | 12.15% |
2016 Q1 | 2.83 Billion DKK | 23.25% |
2016 FY | 3.52 Billion DKK | 53.55% |
2016 Q2 | 2.68 Billion DKK | -5.09% |
2016 Q3 | 3.14 Billion DKK | 17.05% |
2015 Q3 | 2.32 Billion DKK | -1.02% |
2015 Q1 | 2.37 Billion DKK | 41.67% |
2015 Q2 | 2.34 Billion DKK | -1.01% |
2015 Q4 | 2.29 Billion DKK | -1.2% |
2015 FY | 2.29 Billion DKK | 37.13% |
2014 Q2 | 1.6 Billion DKK | 2.23% |
2014 Q4 | 1.67 Billion DKK | -2.16% |
2014 Q3 | 1.71 Billion DKK | 6.8% |
2014 FY | 1.67 Billion DKK | 37.75% |
2014 Q1 | 1.56 Billion DKK | 28.95% |
2013 Q3 | 1 Billion DKK | 14.43% |
2013 Q4 | 1.21 Billion DKK | 20.75% |
2013 FY | 1.21 Billion DKK | 340.58% |
2013 Q1 | 783 Million DKK | 183.7% |
2013 Q2 | 880 Million DKK | 12.39% |
2012 Q2 | - DKK | 0.0% |
2012 Q1 | - DKK | -100.0% |
2012 FY | 276 Million DKK | -79.91% |
2012 Q4 | 276 Million DKK | 0.0% |
2012 Q3 | - DKK | 0.0% |
2011 Q1 | 1.16 Billion DKK | 9.94% |
2011 FY | 1.37 Billion DKK | 30.11% |
2011 Q4 | 1.37 Billion DKK | 15.56% |
2011 Q2 | 1.16 Billion DKK | 0.6% |
2011 Q3 | 1.18 Billion DKK | 1.8% |
2010 Q2 | 1.16 Billion DKK | 3.39% |
2010 FY | 1.05 Billion DKK | -1.31% |
2010 Q1 | 1.12 Billion DKK | 4.86% |
2010 Q3 | 1.1 Billion DKK | -4.48% |
2010 Q4 | 1.05 Billion DKK | -4.69% |
2009 Q4 | 1.07 Billion DKK | 0.0% |
2009 FY | 1.07 Billion DKK | -33.21% |
2008 FY | 1.6 Billion DKK | 23.04% |
2007 FY | 1.3 Billion DKK | 4.16% |
2006 FY | 1.25 Billion DKK | 203.4% |
2005 FY | 412 Million DKK | 258.26% |
2004 FY | 115 Million DKK | -82.52% |
2003 FY | 658 Million DKK | -50.6% |
2002 FY | 1.33 Billion DKK | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Ambu A/S | 512 Million DKK | -630.078% |
ChemoMetec A/S | 974 Thousand DKK | -383678.234% |
Demant A/S | 12.21 Billion DKK | 69.401% |
Scandinavian Medical Solutions A/S | 17.68 Million DKK | -21030.631% |
ViroGates A/S | 5.3 Million DKK | -70428.302% |